| Product Code: ETC13337855 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Infectious Disease Diagnostic Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Infectious Disease Diagnostic Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Infectious Disease Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 North America Infectious Disease Diagnostic Market - Industry Life Cycle |
3.4 North America Infectious Disease Diagnostic Market - Porter's Five Forces |
3.5 North America Infectious Disease Diagnostic Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Infectious Disease Diagnostic Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 North America Infectious Disease Diagnostic Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 North America Infectious Disease Diagnostic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 North America Infectious Disease Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Infectious Disease Diagnostic Market Trends |
6 North America Infectious Disease Diagnostic Market, 2021 - 2031 |
6.1 North America Infectious Disease Diagnostic Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Infectious Disease Diagnostic Market, Revenues & Volume, By Bacterial Infections, 2021 - 2031 |
6.1.3 North America Infectious Disease Diagnostic Market, Revenues & Volume, By Viral Infections, 2021 - 2031 |
6.1.4 North America Infectious Disease Diagnostic Market, Revenues & Volume, By Fungal Infections, 2021 - 2031 |
6.1.5 North America Infectious Disease Diagnostic Market, Revenues & Volume, By Parasitic Infections, 2020 - 2028 |
6.2 North America Infectious Disease Diagnostic Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Infectious Disease Diagnostic Market, Revenues & Volume, By Immunodiagnostics, 2021 - 2031 |
6.2.3 North America Infectious Disease Diagnostic Market, Revenues & Volume, By Molecular Diagnostics, 2021 - 2031 |
6.2.4 North America Infectious Disease Diagnostic Market, Revenues & Volume, By Traditional Diagnostic Techniques, 2021 - 2031 |
6.3 North America Infectious Disease Diagnostic Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Infectious Disease Diagnostic Market, Revenues & Volume, By Hospitals & Clinics, 2021 - 2031 |
6.3.3 North America Infectious Disease Diagnostic Market, Revenues & Volume, By Diagnostic Laboratories, 2021 - 2031 |
6.3.4 North America Infectious Disease Diagnostic Market, Revenues & Volume, By Research Institutes, 2021 - 2031 |
6.3.5 North America Infectious Disease Diagnostic Market, Revenues & Volume, By Home Care Settings, 2021 - 2031 |
7 North America Infectious Disease Diagnostic Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Infectious Disease Diagnostic Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.2.1 United States (US) Infectious Disease Diagnostic Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.2.2 Canada Infectious Disease Diagnostic Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.2.3 Rest of North America Infectious Disease Diagnostic Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3 North America Infectious Disease Diagnostic Market Revenues & Volume Share, By Technology, 2021 & 2031F |
7.3.1 United States (US) Infectious Disease Diagnostic Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.2 Canada Infectious Disease Diagnostic Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.3 Rest of North America Infectious Disease Diagnostic Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4 North America Infectious Disease Diagnostic Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 United States (US) Infectious Disease Diagnostic Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Canada Infectious Disease Diagnostic Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 Rest of North America Infectious Disease Diagnostic Market, Revenues & Volume, By End User, 2021 - 2031 |
8 North America Infectious Disease Diagnostic Market Key Performance Indicators |
9 North America Infectious Disease Diagnostic Market - Export/Import By Countries Assessment |
10 North America Infectious Disease Diagnostic Market - Opportunity Assessment |
10.1 North America Infectious Disease Diagnostic Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Infectious Disease Diagnostic Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
10.3 North America Infectious Disease Diagnostic Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.4 North America Infectious Disease Diagnostic Market Opportunity Assessment, By End User, 2021 & 2031F |
11 North America Infectious Disease Diagnostic Market - Competitive Landscape |
11.1 North America Infectious Disease Diagnostic Market Revenue Share, By Companies, 2022 |
11.2 North America Infectious Disease Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here